These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32943401)

  • 1. Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs.
    Jouet A; Gaudin C; Badalato N; Allix-Béguec C; Duthoy S; Ferré A; Diels M; Laurent Y; Contreras S; Feuerriegel S; Niemann S; André E; Kaswa MK; Tagliani E; Cabibbe A; Mathys V; Cirillo D; de Jong BC; Rigouts L; Supply P
    Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 32943401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB
    Bonnet I; Enouf V; Morel F; Ok V; Jaffré J; Jarlier V; Aubry A; Robert J; Sougakoff W
    Front Cell Infect Microbiol; 2021; 11():707244. PubMed ID: 34778100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
    Sharma MK; Stobart M; Akochy PM; Adam H; Janella D; Rabb M; Alawa M; Sekirov I; Tyrrell GJ; Soualhine H
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of
    He G; Zheng Q; Shi J; Wu L; Huang B; Yang Y
    Microbiol Spectr; 2024 Aug; 12(8):e0334123. PubMed ID: 38904370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies.
    Cabibbe AM; Moghaddasi K; Batignani V; Morgan GSK; Di Marco F; Cirillo DM
    J Clin Microbiol; 2024 Oct; 62(10):e0081524. PubMed ID: 39240079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Whole-Genome Sequencing to Predict
    Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
    Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of AAICare®-TB sequence analysis tool for accurate diagnosis of drug-resistant tuberculosis: A comparative study with TB-Profiler and Mykrobe.
    Singhal R; Hingane S; Bhalla M; Sharma A; Ferdosh S; Tiwari A; Jayaswal P; Yadav RN; Arora J; Dewan RK; Sharma S
    Tuberculosis (Edinb); 2024 Jul; 147():102515. PubMed ID: 38744006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep.
    Jouet A; Braet SM; Gaudin C; Bisch G; Vasconcellos S; Epaminondas Nicacio de Oliveira do Livramento RE; Prado Palacios YY; Fontes AB; Lucena N; Rosa P; Moraes M; La K; Badalato N; Lenoir E; Ferré A; Clément M; Hasker E; Grillone SH; Abdou W; Said A; Assoumani Y; Attoumani N; Laurent Y; Cambau E; de Jong BC; Suffys PN; Supply P
    EBioMedicine; 2023 Jul; 93():104649. PubMed ID: 37327675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China.
    Liu D; Huang F; Zhang G; He W; Ou X; He P; Zhao B; Zhu B; Liu F; Li Z; Liu C; Xia H; Wang S; Zhou Y; Walker TM; Liu L; Crook DW; Zhao Y
    Clin Microbiol Infect; 2022 May; 28(5):731.e9-731.e15. PubMed ID: 34600118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis.
    Tram TTB; Trieu LPT; Nhat LTH; Thu DDA; Quang NL; Bang ND; Chau TTH; Thwaites GE; Walker TM; Ha VTN; Thuong NTT
    J Clin Microbiol; 2024 Apr; 62(4):e0128723. PubMed ID: 38466092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing.
    Cloutier Charette W; Rabodoarivelo MS; Point F; Knoblauch AM; Andrianomanana FR; Hall MB; Iqbal Z; Supply P; Martin A; Rakotosamimanana N; Grandjean Lapierre S
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116249. PubMed ID: 38537504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Five User-Friendly Whole Genome Sequencing Software for
    Kim N; Seok KH; Shin S; Kim B; Park H; Roh EY; Yoon JH; Shin S
    J Korean Med Sci; 2022 Nov; 37(46):e328. PubMed ID: 36631026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GenoMycAnalyzer: a web-based tool for species and drug resistance prediction for Mycobacterium genomes.
    Kim D; Shin JI; Yoo IY; Jo S; Chu J; Cho WY; Shin SH; Chung YJ; Park YJ; Jung SH
    BMC Genomics; 2024 Apr; 25(1):387. PubMed ID: 38643090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.